JOURNAL OF GERIATRIC ONCOLOGY CANCER AND AGING RESEARCH Volume 15 Number 5 June 2024 ISSN 1879-4068 The official journal of the International Society of Geriatric Oncology Volume 15(7) Supplement 1 October 2024 ISSN 1879-4068 Abstracts of the SIOG 2024 Annual Conference 17–19 October, 2024 Montreal, Canada
JOURNAL OF GERIATRIC ONCOLOGY Associate Editors William Dale City of Hope Cancer Center, Duarte, CA, USA Marije Hamaker Diakonessenhuis Utrecht, The Netherlands Heidi Klepin Wake Forest University School of Medicine Winston-Salem, NC, USA Martine Puts Lawrence S. Bloomberg Faculty of Nursing University of Toronto Toronto, Canada Enrique Soto-Perez-de-Celis Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico William Tew Memorial Sloan-Kettering Cancer Center New York, NY, USA Noam VanderWalde University of Tennessee Health Science Center/ West Cancer Center, TN, USA Tanya M. Wildes Washington University School of Medicine St. Louis, Missouri, USA Grant R. Williams The University of Alabama at Birmingham, AL, USA Series Editor: Geriatrics for the Oncologist William Dale City of Hope Cancer Center, Duarte, CA, USA Associate Editor/Liaison to the Young International Society of International Oncology Group (SIOG) Kah Poh Loh University of Rochester Rochester, NY, USA Editorial Board Amina Ahmed Rush University Medical Center Chicago, IL, USA Thomas Aparicio Hôpital Saint Louis Bobigny, France Kimlin T. Ashing-Giwa City of Hope Duarte, CA, USA Laura Biganzoli Hospital of Prato Prato, Italy Etienne Brain Institut Curie - Hôpital René Huguenin Saint Cloud, France Tyler Chesney St. Michael's Hospital ON, Canada Kwok Leung Cheung University of Nottingham Derby Nottingham, United Kingdom Karis Kin Fong Cheng The University of Tokyo Tokyo, Japan Yanin Chávarri Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico Stephen Chun MD Anderson Cancer Center Houston, TX, USA Raul Cordoba Fundacion Jimenez Diaz University Hospital Madrid, Spain Lore Decoster University Hospital Brussels | UZ Brussel Brussels, Belgium Efrat Dotan Fox Chase Cancer Center Philadelphia, PA, USA Martine Extermann H. Lee Moffitt Cancer Center USF Tampa, FL, USA Claire Falandry Centre Hospitalier Lyon Sud France Marie Flannery University of Rochester Medical Center Rochester, NY, USA Fergal Fleming University of Rochester Rochester, NY, USA Chunkit Fung University of Rochester Medical Center Rochester, NY, USA Nikesha Gilmore University of Rochester Medical Center Rochester, NY, USA Nienke de Glas Leiden University Medical Centre The Netherlands Ozan Guler Baskent University Turkey Holly Holmes The University of Texas MD Anderson Cancer Center Houston, TX, USA Aminah Jatoi Mayo Clinic Rochester, MN, USA Ravindran Kanesvaran National Cancer Centre Singapore, Singapore Cindy, Kenis UZ Leuven Leuven, Belgium Gretchen Kimmick Duke University Medical Center Durham, NC, USA Beatriz Korc Memorial Sloan-Kettering Cancer Center New York, NY, USA Jessica Krok-Schoen The Ohio State University Columbus, OH, USA Stuart Lichtman Memorial Sloan-Kettering Cancer Center New York, NY, USA Lisa M. Lowenstein MD Anderson Cancer Center Houston, TX, USA Jennifer L. Lund University of North Carolina at Chapel Hill Chapel Hill, NC, USA Andrea Luciani S. Paulo Hospital Milan, Italy Cecilia Lund Herlev Hospital Denmark Ronald Maggiore University of Rochester Rochester, NY, USA Allison Magnuson University of Rochester Rochester, NY, USA Nicolo Matteo Luca Battisti The Royal Marsden NHS Foundation Trust United Kingdom June M. McKoy Northwestern University - Feinberg School of Medicine Chicago, IL, USA Ishwaria Mohan Subbiah MD Anderson USA Filipe Coutinho Medio Ave Hospital Center, Santo Tirso, Portugal Vicki Morrison University of Minnesota at Twin Cities Minneapolis, MN, USA Christian Nelson Memorial Sloan-Kettering Cancer Center New York, NY, USA Nina Neuendorff University Hospital Essen Germany Ginah Nightingale Thomas Jefferson University Philadelphia, PA, USA Ryan Nipp Harvard University Massachusetts, USA Tracey O'Connor Roswell Park Comprehensive Cancer Center Buffalo, NY, USA Anita O’Donovan Trinity College Dublin, Ireland Rebecca Olin University of California San Francisco (UCSF) San Francisco, CA, USA Erika Ramsdale University of Rochester Rochester, NY, USA Ashley Rosko The Ohio State University Columbus, OH, USA Nicole Saur University of Pennsylvania PA, USA Armin Shahrokni Memorial Sloan Kettering Cancer Center New York, NY, USA Reinhard Stauder Innsbruck Medical University Innsbruck, Austria Christopher Steer Albury Wodonga Regional Cancer Centre Trust Fund Inc., Albury, New South Wales, Australia Catherine Terret Centre Léon Bérard Lyon, France Kelly M. Trevino Weill Cornell Medicine New York, NY, USA Barbara L. van Leeuwen University Medical Center Groningen, The Netherlands Ulrich Wedding Friedrich Schiller University Jena, Germany Hans Wildiers UZ Leuven Leuven, Belgium Melisa Wong University of California San Francisco CA, USA
JOURNAL OF GERIATRIC ONCOLOGY Volume 12, Number 7, September 2021 Amsterdam • Boston • London • New York • Oxford • Paris • Philadelphia • San Diego • St Louis Deputy Editors Siri Rostoft University of Oslo Oslo, Norway Shabbir M.H. Alibhai University Health Network Toronto, Canada Social Media Editor William Dale City of Hope Cancer Center Duarte, CA, USA Founding Editor Matti S. Aapro Multidisciplinary Oncology Institute Clinique de Genolier Genolier, Switzerland Past Editor Arti Hurria Director, Cancer and Aging Research Program City of Hope Duarte, CA, USA Editor-in-Chief Supriya Mohile Director, Geriatric Oncology Research University of Rochester Rochester, NY, USA Assistant to Editor-in-Chief Shuhan Yang and Megan Wells University of Rochester Rochester, NY, USA Editorial Office Emily Crowe Stover Court Bampfylde Street Exeter EX1 2AH, UK Advisory Board Lodovico Balducci H. Lee Moffitt Cancer Center & Research Institute Tampa, FL, USA Harvey Cohen Duke University Medical Center Durham, NC, USA Jean-Pierre Droz Centre Léon Bérard Lyon, France Margaret Kemeny Mt. Sinai School of Medicine Jamaica, NY, USA Silvio Monfardini Don C. Gnocchi Foundation, IRCCS Milan, Italy Hyman Muss University of North Carolina at Chapel Hill School of Medicine Chapel Hill, NC, USA Louise Walter University of California San Francisco (UCSF) San Francisco, CA, USA Nancy Keating Harvard Medical School Boston, Massachusetts, USA Volume 12, Number 8, December 2021 Volume 15(7), Supplement 1, October 2024 Publication of this Abstract Supplement is supported by the International Society of Geriatric Oncology (SIOG). Fiona Stauffer
SIOG 2024 – Contents Track 1: Clinical trials and precision medicine in older adults with cancer Oral Presentation SIOG2024-1-OA-001 – Randomized phase II study of Gemcitabine/Nab-Paclitaxel compared with 5-Fluorouracil/Leucovorin/Liposomal Irinotecan in older patients with treatment-naïve metastatic pancreaticcancer(GIANTEA2186).......................................S1 SIOG2024-1-OA-002 – A prospective geriatric assessment (GA) study predicting toxicities in older adults (OA) with non-hodgkin lymphoma (NHL): timed up and go test (TUG) time emerges as a functional vital sign. . . . . . . . S1 SIOG2024-1-OA-003 – A randomized pilot study of memory and attention adaptation training-geriatrics (MAAT-G) Tomitigate cancer related cognitive decline (CRCD) symptoms in older women with breast cancer. . . . . . . . . S2 SIOG2024-1-OA-004 – Predicting early mortality in older adults with stomach cancer: a machine learning (ML) Approach incorporating comprehensive geriatric assessment (CGA) And clinical data (CD) . . . . . . . . . . . . S3 SIOG2024-1-OA-005 – Examining resilience in symptom response to cancer treatment in older adults with advancedincurable cancer during cancer treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S5 SIOG2024-1-OA-006 – The benefit of geriatric interventions in reducing treatment-related toxicity in older adults withcancer:aSIOGTaskforcesystematicreview.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S6 SIOG2024-1-OA-007 – Unlocking the potential of liquid biopsy applications in personalized care for older adults withcancer:Statement from SIOG (International Society of Geriatric Oncology) Translational Working Group. . . . S6 SIOG2024-1-OA-008 – Examining completion of patient reported outcomes in a multisite clinical trial by older adultswithadvanced cancer: implications for future trial design and conduct. . . . . . . . . . . . . . . . . . . S7 SIOG2024-1-OA-009 – Frailty assessment tools for evaluating older adults prior to surgery by clinicians without geriatricsexpertise:ascopingreview..................................... S8 Poster Presentation SIOG2024-1-P-001 – The role of polypharmacy in identifying older chinese women with breast cancer for comprehensivegeriatricassessment......................................S8 SIOG2024-1-P-002 – Capacity building for clinical trials on geriatric oncology and survivorship: engagement with survivorsandpromotoresdesalud...................................... S8 SIOG2024-1-P-005 – Assessment and management of toxic effects of cancer therapy in elderly patients in Tunisia. . . S9 SIOG2024-1-P-006 – Prophylactic tocilizumab prior to infusion of anti-CD19 CAR-T cells may reduce the incidenceoftoxicityin older lymphoma patients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S9 SIOG2024-1-P-007 – Adjuvant Nivolumab after Chemo-Radiation in Localized Muscle-Invasive Urothelial Cancer: Primaryanalysis of a single-arm phase II investigator-initiated trial (NEXT). . . . . . . . . . . . . . . . . . . S11 SIOG2024-1-P-008 – Clinical characteristics and outcomes of nonagenarian patients with hepatocellular carcinomaunderwent proton beam therapy: a single institutional retrospective study. . . . . . . . . . . . . . S11 SIOG2024-1-P-009 – Feasibility of memory attention and adaptation training-geriatrics (MAAT-G) to improve cancer-relatedcognitive decline (CRCD) in older cancer survivors with mild cognitive impairment (MCI) . . . . . S12 SIOG2024-1-P-010 – Feasibility and acceptability of geriatric assessment and remote symptom monitoring in older menwith advanced prostate cancer on androgen receptor axis targeted therapy. . . . . . . . . . . . . . . . . S13 SIOG2024-1-P-011 – Outcomes of robotic surgery (RS) for older patients (pts) with colorectal cancer (CRC): preliminaryresults of the prospective ROBO-G study. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S14 SIOG2024-1-P-012 – Emergence of APIS BREAST CANCER SUBTYPING KIT as a viable RNA-based risk-stratification toolinolderBCpatients.ResultsfromaSwissCohort.......................................................... S14 SIOG2024-1-P-013 – Geriatric assessment-guided interventions with supportive care: Using telemedicine to increase goalconcordant care for older adults with cancer in the community – CARG GOTO GAIN-S trial in progress . . . . . . . S15 SIOG2024-1-P-014 – Recruitment challenges in a supportive care clinical trial for older men with advanced prostatecancer...............................................S16 SIOG 2021 – Contents Track 1: Solid tumours and basic science Oral Presentations SIOG2021-0009 – Molecular testing in older patients treated for an advanced or metastatic nonsquamous non-small-cell lung cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S1 SIOG2021-0025 – Role of hemi-body radiation in prostate cancer with disseminated bone metastasis in geriatric patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S1 SIOG2021-0038 – Estimating the need for radiotherapy in older women with breast cancer . . . . . . . . . . . . . . . . . . . . . . . . . S2 SIOG2021-0051 – Incidence, treatment, and survival trends in older women with epithelial ovarian cancer from 2005 to 2018: a nationwide Danish study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S2 SIOG2021-0055 – Uptake of Immediate Breast Reconstruction in Older Women Post-Mastectomy- A Systematic Review of the Literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S2 SIOG2021-0077 – Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer (AM-NSCLC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S3 SIOG2021-0109 – Quality of active surveillance (AS) care received by an aging population in low risk prostate cancer: Applying quality indicators to understand quality of care at the population level . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S4 SIOG2021-0121 – Chemotherapy in patients with stage III and IV non-small cell lung cancer (NSCLC) above and below the age of 75 in England: an analysis of the SACT dataset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S4 SIOG2021-0131 – Time trends in treatment strategies and survival of older versus younger patients with synchronous metastasized melanoma – a population-based study in the Netherlands Cancer Registry . . . . . . . . . . . . . S5 SIOG2021-0158 – Chemotherapy use and outcomes in patients with stage III or IV small-cell lung cancer in relation to age: An analysis of the English Systemic Anti-Cancer Treatment (SACT) dataset . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S5 SIOG2021-0170 – Worsening of ovarian cancer prognosis with age: an exploration of pharmacokinetics, body composition, and biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S6 E-Poster Presentations SIOG2021-0012 – Geriatric classification predicts immunological status in old patients diagnosed with non-small cell lung cancer (NSCLC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S6 SIOG2021-0014 – Feasibility of an adapted schedule of carboplatin + paclitaxel in elderly women with Ovarian Cancer: a retrospective cohort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S7 SIOG2021-0016 – Impact of COVID-19 on Older Women Presenting with Breast Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S8 SIOG2021-0023 – Cervical cancer in older women, does age matter? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S8 SIOG2021-0027 – Tolerability and feasibility of oxaliplatin-containing adjuvant chemotherapy for elderly patients with colorectal cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S8 SIOG2021-0031 – The Pivotal Role of Viruses in the Pathogeny of Chronic Lymphocytic Leukemia . . . . . . . . . . . . . . . . . . . S9 SIOG2021-0034 – Age-related safety and efficacy of perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatinanddocetaxel(FLOT)inelderlypatients............................................................ S9 SIOG2021-0035 – A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S9 SIOG2021-0045 – Older patients enrolling in early phase clinical trials; higher rates of sarcopenia, but no increase in toxicity.................................................................................................... S10 SIOG2021-0048 – Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: an observational study . . . . . . S10 SIOG2021-0081 – Adjuvant hyperthermic intravesical chemotherapy in older patients diagnosed with intermediate and high-risk non-muscle invasive bladder cancer: effectiveness and safety . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S10 SIOG2021-0136 – Institutional audit of geriatric patients treated with pencil beam scanning (PBS) proton beam therapy (PBT) – Toxicities and early outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S11 SIOG2021-0141 – Pilot observational study of patients with liver cancer receiving first-line treatment: preliminary data on ADLs, IADLs, and Timed Up and Go (TUG) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S11 Journal of Geriatric Oncology 12 (2021) iii–iv Contents lists available at ScienceDirect Journal of Geriatric Oncology CONTENTS Perspectives S. Monfardini, L. Balducci, J. Overcash, M. Aapro Landmarks in geriatric oncology 991 R.T. Saldivar, W.P. Tew, A. Shahrokni, J. Nelson Goals of care conversations and telemedicine 995 M. Puts, F. Strohschein, W. Oldenmenger, K. Haase, L. Newton, M. Fitch, S. Sattar, P. Stolz-Baskett, R. Jin, A. Loucks, G. Nightingale, C. Kenis Position statement on oncology and cancer nursing care for older adults with cancer and their caregivers of the International Society of Geriatric Oncology Nursing and Allied Health Interest Group, the Canadian Association of Nurses in Oncology Oncology & Aging Special Interest Group, and the European Oncology Nursing Society 1000 Original Research K.L. Schoenbeck, M.A. Fiala, T.M. Wildes Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma 1005 J. McClennon, C. Vonnes, B. Dosal, R.R. Reich, T.M. Mason, M. Extermann Integrating geriatric screening in the clinical setting: Recommendations for older adult oncology patients 1010 H. Xu, S. Kadambi, S.G. Mohile, S. Yang, L.A. Kehoe, M. Wells, E. Culakova, C. Kamen, S. Obrecht, M. Mohamed, N.J. Gilmore, A. Magnuson, V.A. Grossman, J.O. Hopkins, J. Geer, J. Berenberg, K. Mustian, A. Cupertino, N. Mohile, K.P. Loh Caregiving burden of informal caregivers of older adults with advanced cancer: The effects of rurality and education 1015 T. Garg, A. Johns, A.J. Young, M.E. Nielsen, H.-J. Tan, C.K. McMullen, H.L. Kirchner, H.J. Cohen, T.E. Murphy Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder cancer in older adults: A population-based analysis 1022 A. Jochems, E. Bastiaannet, M.J.B. Aarts, A.C.J. van Akkooi, F.W.P.J. van den Berkmortel, M.J. Boers-Sonderen, A.J.M. van den Eertwegh, N.G. de Glas, J.W.B. de Groot, J.B.A.G. Haanen, G.A.P. Hospers, J.J.M. van der Hoeven, D. Piersma, R.S. van Rijn, K.P.M. Suijkerbuijk, A.J. ten Tije, A.A.M. van der Veldt, G. Vreugdenhil, M.C.T. van Zeijl, E. Kapiteijn, M.W.J.M. Wouters Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry 1031 R. Ishii, T. Ogawa, A. Ohkoshi, A. Nakanome, M. Takahashi, Y. Katori Use of the Geriatric-8 screening tool to predict prognosis and complications in older adults with head and neck cancer: A prospective, observational study 1039 S. Pilleron, C. Maringe, H. Charvat, J. Atkinson, E.J.A. Morris, D. Sarfati The impact of timely cancer diagnosis on age disparities in colon cancer survival 1044 T.E. Argillander, D. Spek, H.J. van der Zaag-Loonen, A.F. van Raamt, P. van Duijvendijk, B.C. van Munster Association between postoperative muscle wasting and survival in older patients undergoing surgery for non-metastatic colorectal cancer 1052 X. Zhang, M.L. Pennell, B.M. Bernardo, J. Clark, J.L. Krok-Schoen, B.C. Focht, T.E. Crane, A.H. Shadyab, E.D. Paskett Body image, physical activity and psychological health in older female cancer survivors 1059 S.L. Yoon PhD, L. Scarton PhD, L. Duckworth PhD, Y. Yao PhD, M.O. Ezenwa PhD, M.L. Suarez PhD, R.E. Molokie MD, D.J. Wilkie PhD Pain, symptom distress, and pain barriers by age among patients with cancer receiving hospice care: Comparison of baseline data 1068 Journal of Geriatric Oncology 12(8) (2021) ii–vii Journal of Geriatric Oncology 15(7)S1 (2024) ii–viii patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S1 cell lung cancer (NSCLC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S6 with colorectal cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S8
Contents iii SIOG2024-1-P-015 – Epigallocatechin gallate (EGCG) nutraceutical intervention and physical activity in pre-frail andfrailoldercancersurvivors........................................S16 SIOG2024-1-P-016 – Enzalutamide (Enz) with 5- alpha reductase inhibitors (5-ARI) for older patients (pts) with castrationsensitive systemic prostate cancer (CSPC): effects on fatigue and physical well-being. . . . . . . . . . S17 SIOG2024-1-P-018 – Comprehensive genomics-informed prospective older adult (OA) gastrointestinal (GI) cancer registry:Initial findings from Resilience and Equity in Aging, Cancer, and Health (REACH) registry. . . . . . . . . S17 SIOG2024-1-P-019 – Personalized management of metastatic triple-negative breast cancer in elderly patient: a comprehensiveapproach.......................................... S17 SIOG2024-1-P-020 – Safety and efficacy of chemo-immunotherapy in elderly patients with lung cancer. . . . . . . S18 SIOG2024-1-P-021 – A metaanalysis of clinical trials reporting efficacy of selinexor in acute myeloid leukemia. . . . S19 SIOG2024-1-P-022 – Routine serum biomarkers as risk stratification parameters for older pancreatic cancer patients.Reportsfrom a single center swiss cohort study. . . . . . . . . . . . . . . . . . . . . . . . . . . . S19 SIOG2024-1-P-023 – Precision Oncology in elderly cancer patients: a single-center experience. . . . . . . . . . . S21 SIOG2024-1-P-024 – External validation of the ELFI v2.0: a patient-reported measure of functional status and frailtyindicatoringeriatriconcology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S22 SIOG2024-1-P-025 – Lymphoma in 80 years old man, management by hemato-geriatrics team. . . . . . . . . . . S23 SIOG2024-1-P-027 – Characteristics that determine the classification of patients as robust or frail. . . . . . . . . . S23 SIOG2024-1-P-029 – Representation of older adults in FDA and EMA registrational trials for diffuse large B cell lymphoma(DLBCL)............................................. S24 SIOG2024-1-P-030 – Representation of older adults in FDA and EMA registrational trials for acute myeloid leukemia(AML)...............................................S24 SIOG2024-1-P-031 – Minding the gap: considering culturally and linguistically appropriate clinical trials for diverseolderadultswithcancer....................................... S25 Track 2: Biology and epidemiology in cancer and aging Oral Presentation SIOG2024-2-OA-010 – Ten-year cognition transitions in older cancer survivors in the National Health and Aging TrendsStudy(NHATS)............................................S26 SIOG2024-2-OA-011 – Association of epigenetic age acceleration measures and frailty index in older women with breastcancer................................................ S26 SIOG2024-2-OA-012 – Predicting frailty domain impairments and mortality with the Hospital Frailty Risk Score amongolderadults with cancer: the ELCAPA-EDS cohort study . . . . . . . . . . . . . . . . . . . . . . . . . S27 SIOG2024-2-OA-013 – Association of cancer with frailty at old age in the longitudinal study of aging. . . . . . . . S28 SIOG2024-2-OA-014 – Social vulnerability and mortality in older adults with gastrointestinal cancers - The Cancer&AgingResilience Evaluation (CARE) Registry. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S28 SIOG2024-2-OA-015 – Association of a deficit accumulation electronic frailty index with survival outcomes in a prospectivecohort of older colorectal cancer patients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . S28 SIOG2024-2-OA-016 – Association between adiposity and overall survival in older adults with newly diagnosed gastrointestinal(GI)malignancies...................................... S29 SIOG2024-2-OA-017 – Comorbidity and rates of hospitalizations related to immune-related adverse events (irAEs) amongolder adults with melanoma, a population-based study. . . . . . . . . . . . . . . . . . . . . . . . . S29 SIOG2024-2-OA-018 – Fracture risk following cancer therapies for advanced prostate cancer. . . . . . . . . . . . S30 SIOG2024-2-OA-019 – Evaluating the relationship between anemia, transfusion, and surgical outcomes in surgical geriatriccancerpatients:anationalstudy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S31 Poster Presentation SIOG2024-2-P-033 – Predictive factors for early mortality in older stomach cancer adults: a study utilizing baseline laboratorytests...............................................S31 SIOG2024-2-P-034 – Objective physical function of older prostate cancer survivors and matched controls, a descriptivecomparison........................................... S31 SIOG2024-2-P-035 – Metastatic breast cancer (MBC) patients (pts) ≥70 show prolonged progression-free survival (PFS)compared to pts <70 treated with CDK 4/6 inhibitors: determinants of response and tolerability. . . . . . . S33 SIOG2024-2-P-036 – Sex dimorphism in chronic lymphocytic leukemia correlating with biomarkers of frailty and CIRSscore................................................. S33 SIOG2024-2-P-037 – Breast cancer in elderly women: clinicopathological and prognostic features in Tunisia. . . . . S33 SIOG2024-2-P-038 – Blood-based DNA methylation measures of epigenetic age acceleration in older women with andwithoutbreastcancer..........................................S34 SIOG2024-2-P-039 – Real world population analysis on risk factors for early mortality in older adults with cancer. . S34 SIOG2024-2-P-040 – The impact of general health status assessed by G8 screening tool on overall survival in older patientswith newly diagnosed prostate cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S35 SIOG2024-2-P-041 – Real world safety and efficacy data of CDK4/6 inhibitors plus endocrine therapy in female patientsagedover 65 years with advanced hormone receptor positive her 2 negative breast cancer. . . . . . . . S36
Contents iv SIOG2024-2-P-042 – Comparing CARG and GAH toxicity scores for predicting haematological severe toxicity in olderpatientswith newly diagnosed multiple myeloma. . . . . . . . . . . . . . . . . . . . . . . . . . . . S36 SIOG2024-2-P-043 – Sex disparities in hospital admissions for immune-related adverse events in older adults with lungcancer.................................................S37 SIOG2024-2-P-044 – Chemotherapy toxicity: risk estimation, geriatric variables, and development of toxicity in a sampleofelderly individuals with solid tumors from a latin american reference cancer center . . . . . . . . . . S38 SIOG2024-2-P-045 – A single institution comparative study of a prognostic nomogram model in fit, vulnerable andfrailcohorts of geriatric oncology patients. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S38 SIOG2024-2-P-048 – The effect of global warming on geriatric cancer care. . . . . . . . . . . . . . . . . . . . . S39 Track 3: Strategies and health services research to improve outcomes of diverse populations of older adults with cancer and their caregivers Oral Presentation SIOG2024-3-OA-020 – Protocol for the prevention, early detection and management of delirium in elderly cancer patientsinalatinamericancancerhospital. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S39 SIOG2024-3-OA-021 – Do we underdiagnose dementia in older cancer patients? A descriptive analysis of Brazilian data. . S40 SIOG2024-3-OA-022 – Unveiling the dynamics of medical mistrust and therapeutic alliance (TA) among older blackandwhite adults in cancer care: findings from the PACT study. . . . . . . . . . . . . . . . . . . . . . . S41 SIOG2024-3-OA-023 – Machine learning (ML) analysis of the association of concurrent medication use and comorbidities(CM) with overall survival in senior prostate cancer patients. . . . . . . . . . . . . . . . . . . S42 SIOG2024-3-OA-024 – DIFPAD-Onco, a nurse district screening of frailty’s older adult with cancer at home. . . . . S42 SIOG2024-3-OA-025 – Evaluating heterogeneity in the comparative effectiveness of abiraterone and enzalutamide onskeletal-related events amongst older adult men with metastatic castration resistant prostate cancer . . . . . S43 SIOG2024-3-OA-026 – Impact of G-COMAN, a geriatric-surgical co-management programme, on outcome and processindicators after 1 year of implementation in colorectal surgery. . . . . . . . . . . . . . . . . . . . . S43 SIOG2024-3-OA-027 – What matters most to healthy older adults in treatment decision making: a discrete choice experiment.................................................S44 SIOG2024-3-OA-028 – Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohortstudy................................................ S44 SIOG2024-3-OA-029 – Preliminary findings from the communication on aging and cancer health (COACH 2.0) Implementation project: what it takes to implement the geriatric assessment (GA) In the real world. . . . . . . S45 Poster Presentation SIOG2024-3-P-051 – Reconstructive breast surgery in older women with primary breast cancer. . . . . . . . . . . S46 SIOG2024-3-P-052 – The weight of adverse events in very old breast cancer patients. . . . . . . . . . . . . . . . S46 SIOG2024-3-P-053 – The lived experiences of racialized older adults with cancer in Canada: results of a survey study. . . S47 SIOG2024-3-P-054 – Defining the elderly metastatic cancer survivor population in a latino-majority community. . . S47 SIOG2024-3-P-055 – Exploring disparities: palliative care referrals and survival rates among elderly hispanic and non-hispanic patients with metastatic disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S48 SIOG2024-3-P-056 – Barriers and levers to the implementation of geriatric approach in cancer care, in french patientsandphysicians: a mixed method psychosocial multicenter study. . . . . . . . . . . . . . . . . . . . S50 SIOG2024-3-P-057 – Perioperative optimization of senior health (POSH). . . . . . . . . . . . . . . . . . . . . . S50 SIOG2024-3-P-058 – Oncological decision-making in the oldest old: real-life data from the experience of a Swiss CancerCenter................................................S51 SIOG2024-3-P-059 – Mortality and cause of death in people older than 85 years of age with gastrointestinal cancer: asingle-siteexperience...........................................S51 SIOG2024-3-P-060 – Age disparities in real-world treatment patterns in advanced non-small cell lung cancer, advancedmelanoma, and advanced renal cell carcinoma. . . . . . . . . . . . . . . . . . . . . . . . . . . . S52 SIOG2024-3-P-062 – Estimated savings of a telehealth-based clinical trial on travel-related cost and time burden forolderadultswithcancer......................................... S53 SIOG2024-3-P-063 – The role of healthcare professionals’ attitudes in treatment decision-making for older adultswithcancer:ascopingreview..................................... S53 SIOG2024-3-P-064 – Exploring the status of online social support for older adults with cancer: a scoping review. . . S54 SIOG2024-3-P-065 – Relative dose intensity and survival among older adults with advanced gastrointestinal cancersreceivingfirstlinechemotherapy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S54 SIOG2024-3-P-066 – Characterizing lung cancer screening eligibility, uptake, and fitness for curative treatment amongolderversus younger adults in the United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . S54 SIOG2024-3-P-067 – Social connection among older adults with breast cancer in a pilot trial of an intervention to mitigatecancer-related cognitive decline (CRCD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S55 SIOG2024-3-P-068 – Feasibility of a telehealth-based clinical trial evaluating Memory and Attention Adaptation Training-Geriatrics (MAAT-G) to address symptoms of Cancer Related Cognitive Decline (CRCD) in older adults. . S57
Contents v SIOG2024-3-P-069 – Strategies for improving recruitment of older adults in psychotherapy research. . . . . . . . S58 SIOG2024-3-P-070 – Strategies to increase the racial diversity in a clinical trial of older adults with cancer receivingcancertreatment at an academic institution. . . . . . . . . . . . . . . . . . . . . . . . . . . . . S59 SIOG2024-3-P-071 – Outcomes of older patients with stage I-III triple negative breast cancer (TNBC) Who did not receiveadjuvant chemotherapy: a single institution experience. . . . . . . . . . . . . . . . . . . . . . . . . S59 SIOG2024-3-P-072 – Recommendations for the adaptation of digital medical devices for telemonitoring older patientstreated for cancer: a French national Delphi consensus survey. . . . . . . . . . . . . . . . . . . . . S60 SIOG2024-3-P-073 – Digital dialogues in oncology: exploring a year with the myMarsden app for older adults withcanceratRoyalMarsdenNHS......................................S60 SIOG2024-3-P-074 – The associations between patient-centered communication (PCC) and medical mistrust amongolderblack male and female patients receiving cancer treatment. . . . . . . . . . . . . . . . . . . . . S61 SIOG2024-3-P-076 – Real-world assessment of quality of life in older adults following kidney cancer surgery: experiencefrom a latin american reference cancer center . . . . . . . . . . . . . . . . . . . . . . . . . . . S62 SIOG2024-3-P-077 – Association of smartphone use and internet access with markers of eHealth literacy among adults versus older adults with cancer in Ghana: a hospital-based cross-sectional study. . . . . . . . . . S62 SIOG2024-3-P-078 – “What matters most?” for older patients during cancer survivorship. . . . . . . . . . . . . . . . . . . . . . . . . . S64 SIOG2024-3-P-079 – Survey of healthcare workers’ experiences after implementation of nurse-led geriatric-surgical co-management for patients undergoing colorectal surgery . . . . . . . . . . . . . . . . . . S64 SIOG2024-3-P-080 – Multidisciplinary development of a minimal data set for clinical research in older patients with cancer: a LACOG initiative with international survey. . . . . . . . . . . . . . . . . . . . . . . . . . . S64 SIOG2024-3-P-081 – Understanding treatment-, biliary-related events and survivor outcomes in geriatric and non-geriatric patients with hepatocellular carcinoma: a retrospective study from a single-center experience. . . S65 SIOG2024-3-P-082 – Enhancing communication about cognition for older adults facing dual diagnoses of cancer anddementia and their care partners: adapting the COACH intervention and feedback from key stakeholders. . . S65 SIOG2024-3-P-083 – eHEALTH literacy among spanish older adults with colorectal cancer: A ‘multitec-hosp’ study subanalysis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S66 SIOG2024-3-P-084 – Using the cancer aging and research group- breast cancer (CARG-BC) predictive model in olderadults(OA) with early breast cancer (EBC): an external validation study. . . . . . . . . . . . . . . . . . S67 Track 4: Supportive care delivery in older adults with cancer and their caregivers Oral Presentation SIOG2024-4-OA-030 – Qigong for improving frailty of older cancer survivors: a randomized controlled trial. . . . . S67 SIOG2024-4-OA-031 – Implementation and feasibility study of a remote monitoring system by ePROs (electronic Patient-Reported Outcomes) in older adults patients with cancer based on real-life data in France and Belgium. . S68 SIOG2024-4-OA-032 – Implementing a mutidisciplinary approach for older adults with cancer: challenges and achievmentsa geriatric oncology program in Sao Paulo, Brazil. . . . . . . . . . . . . . . . . . . . . . . . . S68 SIOG2024-4-OA-033 – Prevalence of pre-existing cognitive impairment in patients treated for cancer and the impactofcancer treatment on cognitive outcomes: a scoping review. . . . . . . . . . . . . . . . . . . . . . S69 SIOG2024-4-OA-034 – Exploratory study of virtual reality to assess “Chemo Brain”. . . . . . . . . . . . . . . . . S69 SIOG2024-4-OA-035 – Implementing an electronic geriatric assessment platform (eGAP) in older U.S. Veterans withcancer:apilotstudy.......................................... S70 SIOG2024-4-OA-036 – Prevalence and influencing factors of the dyadic psychological stress among patients with lung cancer and their family caregivers: a cross-sectional study . . . . . . . . . . . . . . . . . . . . . . . . S70 SIOG2024-4-OA-037 – Comparison between computed tomography-based myosteatosis and a frailty index to predict overall mortality in older adults undergoing chemotherapy. . . . . . . . . . . . . . . . . . . . . . . S71 SIOG2024-4-OA-038 – Factors associated with reduced function after radiotherapy (RT) in older adults with cancer. S71 SIOG2024-4-OA-039 – How does receipt of chemotherapy and age affect physical performance in breast cancer patients in the 24 months after diagnosis? Updated Results from the UPBEAT Trial (UPBEAT WF-97415). . . . . . S72 SIOG2024-4-OA-040 – One-year mortality in older adults with breast cancer: prediction using different geriatric tools. . . S73 SIOG2024-4-OA-041 – Gait changes among older adults with myeloid neoplasms after a mobile health exerciseintervention............................................ S73 SIOG2024-4-OA-042 – Feasibility and construct validity of administering pictorial fit frail scale in older patients: amulti-institutionalstudy..........................................S74 SIOG2024-4-OA-043 – The effect of comprehensive geriatric assessment on perioperative outcomes in older adultswithcancer undergoing surgery: a systematic review. . . . . . . . . . . . . . . . . . . . . . . . . . S75 SIOG2024-4-OA-044 – Gait speed as a predictive marker of outcomes after lung resection. . . . . . . . . . . . . S75 SIOG2024-4-OA-045 – Effect of the best case/worst case-geriatric oncology (BC/WC-GeriOnc) communication tool on shared decision making (SDM): a pilot cluster randomized controlled trial. . . . . . . . . . . . . . . . S76 SIOG2024-4-OA-046 – The association between psychosocial factors and decision making regarding primary treatmentinolder women with early-stage breast cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . S77 SIOG2024-4-OA-047 – Engaging patient, caregiver, and healthcare professional stakeholders in geriatric hematologyresearch............................................ S77
Contents vi SIOG2024-4-OA-048 – Enhancing geriatric assessment implementation in Japan: insights from the ENSURE-GAstudy..............................................S78 SIOG2024-4-OA-049 – Systematic screening for supportive care needs among older adults with lung cancer at a comprehensive cancer center: a patient navigation initiative. . . . . . . . . . . . . . . . . . . . . . . . . . S79 SIOG2024-4-OA-050 – Implementation and outcomes of the older adults surgery and oncology program, PRIME, in the care of older adults undergoing gastrointestinal cancer surgery. . . . . . . . . . . . . . . . . . . . . . S79 SIOG2024-4-OA-051 – The development of the senior adult oncology programme at the Royal Marsden NHS foundationtrust.............................................. S80 Poster Presentation SIOG2024-4-P-085 – Influence of age and self-stigmatisation on social eating issues in outpatients with and beyondheadandneck cancer: a mixed-method study. . . . . . . . . . . . . . . . . . . . . . . . . . . . . S80 SIOG2024-4-P-088 – Patient-level predictors of geriatric assessment-driven referral to occupational or physical therapyforolderadultswithadvancedcancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S81 SIOG2024-4-P-089 – Function, quality of life, and survival among older adults with advanced cancer: differences bygeriatricassessment-driven referral to occupational or physical therapy . . . . . . . . . . . . . . . . . . . S81 SIOG2024-4-P-090 – Treatment decision-making tools for older adults with cancer: a scoping review. . . . . . . . S82 SIOG2024-4-P-091 – Assessing frailty and burden in older adults with cancer and their caregivers. . . . . . . . . . S82 SIOG2024-4-P-092 – Geriatric assessment and management of older adults with non-small cell lung cancer (NSCLC) Receiving chemotherapy/Radiation (GAM-CRT): trial in progress. . . . . . . . . . . . . . . . . . . . S82 SIOG2024-4-P-093 – Implementation of a structured geriatric assessment program in an academic setting: results, perception and awareness by patients and treating physicians. . . . . . . . . . . . . . . . . . . . . . . . . S83 SIOG2024-4-P-094 – Impact of income on physical/emotional concerns and help-seeking by adult survivors of cancer (65+ years). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S84 SIOG2024-4-P-095 – Geriatric assessment in older adults with acute myeloid leukemia treated with azacytidine-venetoclax: differences according to TP53 status. . . . . . . . . . . . . . . . . . . . . . . . . . S84 SIOG2024-4-P-096 – Visiting nurse care for elderly cancer patients who self-administer oral anticancer drugs athome:aqualitativestudy......................................... S85 SIOG2024-4-P-097 – Prediction model for treatment-related toxicities in older adults with cancer: a systematic reviewandmeta-analysis.......................................... S85 SIOG2024-4-P-098 – The lack of a standardized geriatric evaluation tool in studies investigating systemic anti-cancer treatments. A systematic literature review. . . . . . . . . . . . . . . . . . . . . . . . . . . . . S85 SIOG2024-4-P-099 – Optimizing care for elderly breast cancer (EBC) Patients: Insights from SeniorERA (Encouraging resilience in aging) assessments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S86 SIOG2024-4-P-101 – Age as factor of palliative care utilization in cancer patients. . . . . . . . . . . . . . . . . . S86 SIOG2024-4-P-102 – Geriatric assessment in older adults with acute myeloid leukemia: a prospective study. . . . . S87 SIOG2024-4-P-103 – Introducing ASCO’s practical geriatric assessment (PGA) and incorporating geriatric oncologyexpertise via telehealth to enhance patient-centred care in rural Australia. . . . . . . . . . . . . . . S87 SIOG2024-4-P-104 – Improving outcomes for older adults undergoing radiation treatment – prospective cohortstudy................................................ S88 SIOG2024-4-P-105 – Evaluation of the american college of surgeons surgical risk calculator in older adults undergoinggastrointestinal cancer surgery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S88 SIOG2024-4-P-106 – SONATA: Development, adaptation, and testing of a novel social network intervention for olderadultswithcancer...........................................S89 SIOG2024-4-P-107 – Implementation of geriatric-oncology multidisciplinary care in Hong Kong. . . . . . . . . . S90 SIOG2024-4-P-108 – Using a 4Ms model for inpatient fall and injury prevention in an age-friendly cancer center. . . S90 SIOG2024-4-P-109 – An inpatient advanced care practitioner-led Serious Illness Care Program for older adults with hematologicmalignancies..........................................S90 SIOG2024-4-P-110 – Representation of Geriatric Oncology in cancer care guidelines in Europe: a scoping review. . . S91 SIOG2024-4-P-111 – Assessment of primary caregivers’ unmet needs when caring for older patients diagnosed withhaematologicalmalignancies...................................... S92 SIOG2024-4-P-112 – Impact of Memory Attention and Adaptation Training-Geriatrics (MAAT-G) on patients’ confidence in cognitive abilities and relationship to performance on objective cognitive assessment. . . . . . . S92 SIOG2024-4-P-113 – Relationship between patients’ perceived benefits from study participation and gratitude inolder adults with cancer participating in a behavioral intervention clinical trial. . . . . . . . . . . . . . . . S93 SIOG2024-4-P-114 – A review of body composition in older adults undergoing systemic anticancer treatment within the senior adult oncology programme at The Royal Marsden . . . . . . . . . . . . . . . . . . . . . . S95 SIOG2024-4-P-115 – Practical application of strategies to mitigate Cancer Related Cognitive Decline (CRCD) symptomsinolderadultswithbreastcancer.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S95 SIOG2024-4-P-116 – Living with and beyond cancer: What older adults tell us about healthy aging. . . . . . . . . S97 SIOG2024-4-P-117 – An integrated fall prevention strategy in older adults with cancer: the experience of the Leon BerardComprehensive Cancer Center Lyon, France. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S97 SIOG2024-4-P-118 – Implementation of a multi-disciplinary geriatric oncology clinic in Toronto, Canada. . . . . . . S97
Contents vii SIOG2024-4-P-119 – Trial in process: E-intervention for protein intake and resistance training to optimize function(E-PROOF)Study.......................................... S98 SIOG2024-4-P-120 – Exercise in older adults with advanced cancer: a scoping review . . . . . . . . . . . . . . . S98 SIOG2024-4-P-121 – PercepTion on virtuAl exeRcise proGram for mEn with prosTate cancer: The TARGET Study. . . S98 SIOG2024-4-P-123 – What matters most to the geriatric surgical oncology patient: a geriatric surgical verificationproject............................................. S99 SIOG2024-4-P-124 – Development of a new patient reported outcome to assess depression in older adults with cancer:preliminary psychometric properties. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S99 SIOG2024-4-P-125 – Psychometric properties of the generalized anxiety disorder scale (GAD-7) in older adults withadvancedcancer...........................................S100 SIOG2024-4-P-126 – Frailty and functional health in older adults receiving systemic therapy. . . . . . . . . . . . S101 SIOG2024-4-P-127 – Recruitment of older adults with myeloid neoplasms based on consent methods in a pilot randomized controlled trial of a mobile health exercise intervention (GO-EXCAP 2). . . . . . . . . . . . . . . S101 SIOG2024-4-P-128 – The CHAMP tool: feasibility and patient satisfaction in geriatric cancer care. . . . . . . . . . S102 SIOG2024-4-P-130 – Recovery after major elective surgery in frail older adults: survey results from the frail sub-studyoftheFITAfterSurgerystudy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S102 SIOG2024-4-P-132 – Attitudes to aging mediate the relationship between loneliness and anxiety/depression inolderadultswithcancer.........................................S103 SIOG2024-4-P-133 – A cost-effective tool for measuring sarcopenia in elderly patients with cancer. . . . . . . . . S103 SIOG2024-4-P-134 – My patient screened positive for cognitive impairment: what do I do next?. . . . . . . . . . S104 SIOG2024-4-P-135 – Occupational therapy’s role in end-of-life care for older adults with cancer. . . . . . . . . . S105 SIOG2024-4-P-136 – Designing and implementing virtual interdisciplinary geriatric oncology review (VIGOR) rounds:anovelmodelforcarecoordination. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S106 SIOG2024-4-P-137 – Enrollment of older adults with newly diagnosed acute myeloid leukemia to a shared decision making intervention trial – barriers and lessons learned. . . . . . . . . . . . . . . . . . . . . . . S106 SIOG2024-4-P-138 – Enhanced prehabilitation: a supportive oncology model before radical cystectomy. . . . . . S107 SIOG2024-4-P-139 – Predictive value of the cancer and aging research group geriatric score for chemotherapy toxicities in older adults with cancer: a systematic review and metaanalysis. . . . . . . . . . . . . . . . . . S107 SIOG2024-4-P-140 – Health outcome prioritization to elicit the preferences of older patients with cancer (HOPEstudy)–astudyprotocol.......................................S108 SIOG2024-4-P-141 - Using remote physiotherapy assessment to identify sarcopenia in older adults with cancer, receivingsystemicanti-cancertreatment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S108 SIOG2024-4-P-142 – Feasibility and acceptability of training nurses in brief meaning centered psychotherapy for homebound individuals (MCP-H) with advanced cancer: open pilot study. . . . . . . . . . . . . . . . . . . S108 SIOG2024-4-P-144 – Feasibility of using wearables to track daily step count in older adults prior to thoracic surgery.................................................. S109 SIOG2024-4-P-145 – Geriatric assessment in older adults with metastatic breast cancer: a pilot study. . . . . . . S109 SIOG2024-4-P-146 – A gender analysis of older adults cancer self-management. . . . . . . . . . . . . . . . . . S110 SIOG2024-4-P-147 – Are you sleeping well? Reports from older adults with cancer. . . . . . . . . . . . . . . . S110 SIOG2024-4-P-148 – Examining the intersection of psychologic distress, frailty, and aging among myeloma patientsandcaregiversperi-transplant. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S111 SIOG2024-4-P-149 – Supporting older adults with cancer and their support person through geriatric assessment and remote exercise and education: Examining recruitment and feasibility in the SOAR trial. . . . . . . . . . . S111 SIOG2024-4-P-150–UHSSHINEservice.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S112 SIOG2024-4-P-151 – Inclusion of caregivers in the CGA-future directions for optimizing clinical care. . . . . . . . S112 SIOG2024-4-P-152 – Geriatric assessment for older adults with cancer: analyses of clinician feasibility and satisfaction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S113 SIOG2024-4-P-153 – Evaluating geriatric assessments and driven interventions in older adults with breast, lung and gastrointestinal cancer: a retrospective analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . S113 SIOG2024-4-P-154 – Exploring the occupational needs of older adults living with cancer: initial findings from a new occupational therapy service within a geriatric oncology clinic in ireland. . . . . . . . . . . . . . S113 SIOG2024-4-P-155 – Implementation challenges seen in GA models: learning from others’ barriers. . . . . . . . . S114 SIOG2024-4-P-156 – Prevalence of probable sarcopenia in a cohort of older cancer patients. . . . . . . . . . . . S115 SIOG2024-4-P-158 – Evaluating the uptake and role of clinical frailty score assessment in patients with upper gastrointestinal cancer in Leeds Teaching Hospitals NHS Trust. . . . . . . . . . . . . . . . . . . . . . . . . S115 SIOG2024-4-P-159 – Associated factors with vulnerabily in elderly patients with cancer. . . . . . . . . . . . . . S115 SIOG2024-4-P-162 – Resiliency among older adults receiving lung cancer treatment (ROAR-LCT): a physical therapy (PT) and progressive muscle relaxation (PMR) intervention for patients with advanced lung cancer. . . S116 SIOG2024-4-P-163 – Efficacy and acceptability of early advanced care planning visits and a telehealth format in youngerandolderpatientswithglioblastoma.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S116 SIOG2024-4-P-164 – Sexual health in elderly indian gynecological cancer survivors . . . . . . . . . . . . . . . . S117 SIOG2024-4-P-165 – Retrospective cohort study on cancer treatment modifications in older adults with pre-existingcognitiveimpairment..................................... S117
RkJQdWJsaXNoZXIy MTk3NTQxMg==